Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (371-380 of 606) with videos related to

Pageof 61
Sort By:
European Journal of Medicinal Chemistry|July 25, 2013
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylationHwan Jung Lim, Christina M Dersch, Richard B Rothman, et al.
Journal of Medicinal Chemistry|April 9, 2008
Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transportersLing-Wei Hsin, Li-Te Chang, Richard B Rothman, et al.
Annals of the New York Academy of Sciences|July 10, 2002
Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependenceMichael H Baumann, Jennifer M Phillips, Mario A Ayestas, et al.
Annals of the New York Academy of Sciences|November 21, 2000
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addictionR B Rothman, J S Partilla, C M Dersch, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909)Y Zhang, R B Rothman, C M Dersch, et al.
The American Journal of Cardiology|April 12, 2000
Chronic treatment with phentermine combined with fenfluramine lowers plasma serotoninR B Rothman, J B Redmon, S K Raatz, et al.
Annals of the New York Academy of Sciences|November 16, 2004
Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brainMichael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.
Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.
Peptides|March 1, 1990
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.
Pageof 61

Showing results (371-380 of 606) with videos related to

Sort By:
Pageof 61
European Journal of Medicinal Chemistry|July 25, 2013
Probes for narcotic receptor mediated phenomena. 48. C7- and C8-substituted 5-phenylmorphan opioids from diastereoselective alkylationHwan Jung Lim, Christina M Dersch, Richard B Rothman, et al.
Journal of Medicinal Chemistry|April 9, 2008
Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transportersLing-Wei Hsin, Li-Te Chang, Richard B Rothman, et al.
Annals of the New York Academy of Sciences|July 10, 2002
Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependenceMichael H Baumann, Jennifer M Phillips, Mario A Ayestas, et al.
Annals of the New York Academy of Sciences|November 21, 2000
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addictionR B Rothman, J S Partilla, C M Dersch, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909)Y Zhang, R B Rothman, C M Dersch, et al.
The American Journal of Cardiology|April 12, 2000
Chronic treatment with phentermine combined with fenfluramine lowers plasma serotoninR B Rothman, J B Redmon, S K Raatz, et al.
Annals of the New York Academy of Sciences|November 16, 2004
Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brainMichael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.
Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.
Peptides|March 1, 1990
Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brainR B Rothman, V Bykov, B R de Costa, et al.
Pageof 61